Published in Science on March 10, 1995
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med (1996) 6.13
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol (1997) 4.70
Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev (1999) 4.39
Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A (1999) 3.86
Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A (1999) 3.85
Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity (2007) 3.84
Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med (1998) 3.72
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med (1996) 3.66
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med (1996) 3.56
Metalloproteinase-mediated release of human Fas ligand. J Exp Med (1995) 3.53
Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J (1998) 3.03
Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun (2003) 3.01
Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A (1996) 2.85
The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med (1997) 2.83
The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol (2004) 2.74
The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci U S A (1996) 2.62
Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A (1996) 2.53
Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics (2010) 2.52
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med (1996) 2.39
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun (1998) 2.34
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34
Multiple myeloma: increasing evidence for a multistep transformation process. Blood (1998) 2.29
Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol (1999) 2.25
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19
Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol (2001) 2.18
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest (1998) 2.16
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood (2006) 2.16
RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity (1998) 2.15
Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension (2008) 2.14
Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol (1996) 2.14
Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J (1997) 2.09
Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol (2001) 2.08
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum (2002) 2.08
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med (1998) 2.03
Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci U S A (1997) 2.02
Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.94
Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut (2001) 1.92
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol (1997) 1.88
Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol (1999) 1.88
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut (1998) 1.88
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85
Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol (1998) 1.85
Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med (1997) 1.85
A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol (1999) 1.84
The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest (2001) 1.82
Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82
Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med (2001) 1.82
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev (2002) 1.80
Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med (1996) 1.80
The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol (2000) 1.80
Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci U S A (1997) 1.78
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med (2000) 1.77
Negative selection in the thymus includes semimature T cells. J Exp Med (1997) 1.77
Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB. Proc Natl Acad Sci U S A (1997) 1.76
Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut (1999) 1.75
Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med (1998) 1.74
The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep (2003) 1.73
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J (1999) 1.73
Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol (2001) 1.73
Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol (1999) 1.72
Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med (2004) 1.72
Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A (1999) 1.71
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol (1998) 1.70
Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci U S A (1997) 1.69
Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J Immunol (2005) 1.69
Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci U S A (1997) 1.68
Necrotic death pathway in Fas receptor signaling. J Cell Biol (2000) 1.68
Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med (1997) 1.66
Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest (1997) 1.66
Fas and the art of lymphocyte maintenance. J Exp Med (1996) 1.65
Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med (1999) 1.63
Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J Exp Med (1996) 1.62
A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol (1996) 1.62
The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci U S A (1998) 1.60
LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A (1997) 1.58
Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med (1998) 1.57
Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol (2004) 1.56
Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc Natl Acad Sci U S A (1998) 1.56
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A (1999) 1.56
Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci U S A (1997) 1.56
Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med (1997) 1.56
Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med (1996) 1.55
Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest (1996) 1.55
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med (1997) 1.53
The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol (2006) 1.52
Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med (1996) 1.52
Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med (1997) 1.52
Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med (1997) 1.51
Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A (1998) 1.51
Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol (2000) 1.50
Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. J Cell Biol (1997) 1.50
Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med (1996) 1.49
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34
A new member of the immunoglobulin superfamily--CTLA-4. Nature (1987) 5.10
Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (1985) 5.06
Fas and Fas ligand: lpr and gld mutations. Immunol Today (1995) 4.69
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med (1993) 4.53
CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol (1993) 3.74
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med (1972) 3.00
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol (1991) 2.92
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol (1982) 2.47
Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol (1988) 2.45
Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol (1999) 2.11
Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes. J Exp Med (1971) 2.09
Programmed cell death in Dictyostelium. J Cell Sci (1994) 1.73
TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med (1995) 1.64
Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity: efficiency of very small amounts of highly purified T cells. Cell Immunol (1973) 1.64
Fas and Fas ligand: a death factor and its receptor. Adv Immunol (1994) 1.63
The inducible cytotoxic T-lymphocyte-associated gene transcript CTLA-1 sequence and gene localization to mouse chromosome 14. Nature (1986) 1.61
Mechanism of T-cell-mediated cytolysis: the lethal hit stage. Contemp Top Immunobiol (1977) 1.61
Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol (1994) 1.58
T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol (1994) 1.40
The lethal hit stage of mouse T and non-T cell-mediated cytolysis: differences in cation requirements and characterization of an analytical "cation pulse" method. Eur J Immunol (1976) 1.26
Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin. J Exp Med (1984) 1.23
Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies. Immunol Rev (1982) 1.18
Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol (1989) 1.15
Functional fractionation of human cytotoxic cells using differences in their cation requirements. Nature (1975) 1.15
LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas. Nature (1982) 1.15
A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA genes. Immunol Rev (1988) 1.13
The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity. J Exp Med (1995) 1.11
Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells). Cell Immunol (1974) 1.10
Homology between reaper and the cell death domains of Fas and TNFR1. Cell (1995) 1.10
Apparent caspase independence of programmed cell death in Dictyostelium. Curr Biol (1998) 1.09
Characterization of an Lyt-1+ cytolytic T-cell clone specific for a polymorphic domain of the I-Ak molecule. Scand J Immunol (1982) 1.06
A necrotic cell death model in a protist. Cell Death Differ (2006) 1.05
Mutations in the Fas antigen gene in lpr mice. Semin Immunol (1994) 1.05
Fas and other cell death signaling pathways. Semin Immunol (1997) 1.04
Sensitivity of cytotoxic T cells to T-cell mediated cytotoxicity. Nature (1974) 1.04
More than one way to go. Proc Natl Acad Sci U S A (2001) 1.04
Self-sparing of long-term in vitro-cloned or uncloned cytotoxic T lymphocytes. J Exp Med (1986) 1.04
CTLA-1 and CTLA-3 serine esterase transcripts are detected mostly in cytotoxic T cells, but not only and not always. J Immunol (1987) 1.03
Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells. Immunogenetics (1982) 1.03
Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+. Immunology (1980) 1.01
Divalent cation requirements as a tool for the study of cell-mediated cytotoxocity systems. Adv Exp Med Biol (1976) 1.00
Cytotoxic immune cells with specificity for defined soluble antigens. II. Chasing the killing cells. Cell Immunol (1973) 0.98
An insertional mutagenesis approach to Dictyostelium cell death. Cell Death Differ (1998) 0.98
Requirement for hexose, unrelated to energy provision, in T-cell-mediated cytolysis at the lethal hit stage. J Exp Med (1978) 0.97
Target cell recognition by cytolytic T cells: different requirements for the formation of strong conjugates or for proceeding to lysis. J Immunol (1979) 0.95
T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia. J Exp Med (1978) 0.94
Mouse T cell-mediated cytolysis specifically triggered by cytophilic xenogeneic serum determinants: a caveat for the interpretation of experiments done under "syngeneic" conditions. J Immunol (1978) 0.94
Lymphocyte activation and effector functions. Editorial overview. The role of cell surface molecules. Curr Opin Immunol (1993) 0.94
Sensitivity of H-2-less target cells and role of H-2 in T-cell-mediated cytolysis. Nature (1976) 0.93
T cell-mediated cytolysis: on the strength of effector-target cell interaction. Eur J Immunol (1983) 0.93
Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains. J Immunol (1983) 0.93
Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philos Trans R Soc Lond B Biol Sci (1994) 0.90
Mechanism of T cell-mediated cytolysis: the differential impact of cytochalasins at the recognition and lethal hit stages. Eur J Immunol (1978) 0.90
Cytotoxic immune cells with specificity for defined soluble antigens. 3. Separation from helper cells and from antibody-forming cell precursors. Transplant Proc (1973) 0.89
Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones. Eur J Immunol (1995) 0.89
Detachment of L cells in the presence of normal mouse spleen cells in vitro; a quantitative study. Clin Exp Immunol (1970) 0.89
Cytotoxic and fluorescent assays for thymocyte subpopulations differing in surface thy-1 level. Cell Biophys (1979) 0.89
Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors. J Immunol (1985) 0.89
Granulocyte colony-stimulating factor and its receptor. Prog Growth Factor Res (1991) 0.89
Recognition by cytolytic T and K cells: identification in both systems of a divalent cation-independent, cytochalasin A-sensitive step. J Immunol (1978) 0.88
Granulocyte colony-stimulating factor receptor and its related receptors. Growth Factors (1993) 0.88
Cytolytic T-cell melodrama. Nature (1987) 0.87
Cell membrane-mediated cytolysis by membranes from noncytolytic cells. Eur J Immunol (1978) 0.87
Production and main characteristics of a fetal calf serum-specific cell line that induces T and B cell differentiation. Scand J Immunol (1980) 0.86
Dismantling in cell death: molecular mechanisms and relationship to caspase activation. Scand J Immunol (1998) 0.86
Non-T cell-mediated cytolysis of antibody-coated sheep red blood cells requires Mg++ but not Ca++: An argument against a conventional "stimulus-secretion" mechanism for cytolysis. J Immunol (1975) 0.85
Apoptosis mediated by the Fas system. Prog Mol Subcell Biol (1996) 0.84
Fas-based d10S-mediated cytotoxicity requires macromolecular synthesis for effector cell activation but not for target cell death. Philos Trans R Soc Lond B Biol Sci (1994) 0.84
Reproducible dissociation of cellular aggregates with a wide range of calibrated shear forces: application to cytolytic lymphocyte target cell conjugates. J Immunol Methods (1983) 0.83
Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy (2003) 0.83
Xenoserum-induced cytolytic "T" cells: polyclonal specificity with an apparent "anti-self" component, and cooperative induction. Immunobiology (1979) 0.83
Xenogeneic serum-induced mouse T cells that trigger the differentiation of precursor into cytolytic T cells. J Immunol (1980) 0.83
Generation of H-2-reactive T cell lines that bear the 5936 idiotype(s). J Immunol (1980) 0.83
Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice. Eur J Immunol (1995) 0.82
Autophagic or necrotic cell death triggered by distinct motifs of the differentiation factor DIF-1. Cell Death Differ (2008) 0.82
Lymphocyte activation: T-cell regulation by CTLA-4. Curr Biol (1996) 0.82
Autonomy of thymus-processed lymphocytes (T cells) for their education into cytotoxic cells. Eur J Immunol (1972) 0.82
Specific adsorption of cytotoxic thymus-processed lymphocytes (T cells) on glutaraldehyde-fixed fibroblast monolayers. Eur J Immunol (1972) 0.81
Cytotoxic immune cells with specificity for defined soluble antigens. I. Assay with antigen-coated target cells. Cell Immunol (1973) 0.81
CTLA-4 and CD28: similar proteins, neighbouring genes. Int J Cancer Suppl (1992) 0.80
Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes. Genomics (1992) 0.80
Cell death in us and others. Science (1998) 0.79
[A technic for quantitative determination of cellular detachment by labelling with 51Cr]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.78
[Reparation phenomena after thermal shock in vitro on mouse embryo cells]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.78
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study. Acta Gastroenterol Belg (2010) 0.78
Unexpected cell surface labeling in conjugates between cytotoxic T lymphocytes and target cells. J Histochem Cytochem (1985) 0.78
The extent of specific adsorption of cytotoxic educated thymus cells: evolution with time and number of injected cells. Cell Immunol (1973) 0.78
Individual variations in the correlation between erythemal threshold, UV-induced DNA damage and sun-burn cell formation. J Photochem Photobiol B (2001) 0.77
Cell-mediated cytostasis: a critical analysis of methodological problems. Cell Immunol (1979) 0.77
Proximity of the CTLA-1 serine esterase and Tcr alpha loci in mouse and man. Immunogenetics (1988) 0.77
Methods to study cell death in Dictyostelium discoideum. Methods Cell Biol (2001) 0.77
On T-cell-mediated cytotoxicity. Transplant Proc (1973) 0.76
Primary in vitro mouse B-cell response induced by self-hormone-coupled self-albumin. Immunology (1982) 0.75